Literature DB >> 15964795

Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage.

Michael Berger1, Nathalie Stahl, Giannino Del Sal, Ygal Haupt.   

Abstract

Tumor suppression by the p53 protein largely depends on the elimination of damaged cells by apoptosis. Mutations in the polyproline region (PPR) of p53 impair its apoptotic function. Deletion of the PPR renders p53 more sensitive to inhibition by Mdm2 via an unknown mechanism. We have explored the mechanism by which the PPR modulates the p53/Mdm2 loop. Proline 82 of p53 was identified to be essential for its interaction with the checkpoint kinase 2 (Chk2) and consequent phosphorylation of p53 on serine 20, following DNA damage. These physical and functional interactions are regulated by Pin1 through cis-trans isomerization of proline 82. Our study unravels the pathway by which Pin1 activates p53 in response to DNA damage and explains how Pin1 protects p53 from Mdm2. Further, we propose a role for Pin1-dependent induction of p53 conformational change as a mechanism responsible for the enhanced interaction between p53 and Chk2 following DNA damage. Importantly, our findings elucidate the selection for mutations in the Pin1 target Thr81/Pro82 motif within the PPR of p53 in human cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964795      PMCID: PMC1156984          DOI: 10.1128/MCB.25.13.5380-5388.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  A role for the polyproline domain of p53 in its regulation by Mdm2.

Authors:  M Berger; R Vogt Sionov; A J Levine; Y Haupt
Journal:  J Biol Chem       Date:  2000-10-26       Impact factor: 5.157

2.  The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.

Authors:  Nicole Baptiste; Philip Friedlander; Xinbin Chen; Carol Prives
Journal:  Oncogene       Date:  2002-01-03       Impact factor: 9.867

3.  Pin1 acts catalytically to promote a conformational change in Cdc25.

Authors:  P T Stukenberg; M W Kirschner
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

4.  DNA damage-induced activation of p53 by the checkpoint kinase Chk2.

Authors:  A Hirao; Y Y Kong; S Matsuoka; A Wakeham; J Ruland; H Yoshida; D Liu; S J Elledge; T W Mak
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

Review 5.  The cellular response to p53: the decision between life and death.

Authors:  R V Sionov; Y Haupt
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

6.  Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

Authors:  J Falck; C Lukas; M Protopopova; J Lukas; G Selivanova; J Bartek
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

7.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Authors:  S Y Shieh; J Ahn; K Tamai; Y Taya; C Prives
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

8.  Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

Authors:  N H Chehab; A Malikzay; M Appel; T D Halazonetis
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

9.  Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity.

Authors:  J Zhu; J Jiang; W Zhou; K Zhu; X Chen
Journal:  Oncogene       Date:  1999-03-25       Impact factor: 9.867

10.  Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.

Authors:  A Ryo; M Nakamura; G Wulf; Y C Liou; K P Lu
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

View more
  26 in total

1.  Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2.

Authors:  Ekaterina Gresko; Ana Roscic; Stefanie Ritterhoff; Anton Vichalkovski; Giannino del Sal; M Lienhard Schmitz
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

Review 2.  Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?

Authors:  Peter E Shaw
Journal:  EMBO Rep       Date:  2007-01       Impact factor: 8.807

3.  The proline rich domain of p53 is dispensable for MGMT-dependent DNA repair and cell survival following alkylation damage.

Authors:  Katherine Baran; Mao Yang; Christopher P Dillon; Leona L Samson; Douglas R Green
Journal:  Cell Death Differ       Date:  2017-07-28       Impact factor: 15.828

4.  Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma.

Authors:  Brian L Teng; Kathryn E Hacker; Shufen Chen; Anthony R Means; W Kimryn Rathmell
Journal:  Mol Oncol       Date:  2011-06-28       Impact factor: 6.603

Review 5.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

6.  Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.

Authors:  Tao Liu; Yu Liu; Hung-Ying Kao; Dehua Pei
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

Review 7.  Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.

Authors:  Yih-Cherng Liou; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Trends Biochem Sci       Date:  2011-08-17       Impact factor: 13.807

8.  An unusual two-step control of CPEB destruction by Pin1.

Authors:  Morris Nechama; Chien-Ling Lin; Joel D Richter
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

9.  Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway.

Authors:  Jiin-Tarng Wang; Shin-Lian Doong; Shu-Chun Teng; Chung-Pei Lee; Ching-Hwa Tsai; Mei-Ru Chen
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

10.  The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway.

Authors:  Nicola J Maclaine; Ted R Hupp
Journal:  Aging (Albany NY)       Date:  2009-05-07       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.